Perceptive Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Perceptive Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,551	Closed	-$19K	–	234
2016 Q4	$19K	Buy	+1,551	New	+$18.7K	﹤0.01%	159
2016 Q1	–	Sell	-50,000	Closed	-$313K	–	198
2015 Q4	$313K	Sell	50,000 -400,000	-89%	-$2.63M	0.02%	107
2015 Q3	$2.63M	Buy	450,000 +258,051	+134%	+$1.99M	0.21%	72
2015 Q2	$1.59M	Buy	191,949 +150,000	+358%	+$1.33M	0.1%	105
2015 Q1	$346K	Buy	+41,949	New	+$310K	0.03%	120

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Perceptive Advisors's ARIA Position: Q1 2017 in Review

Perceptive Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,551 shares — an estimated $19K sold.

Perceptive Advisors first reported a position in ARIA in Q1 2015 and held it in 5 quarters. The position peaked at $2.63M in Q3 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Perceptive Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Perceptive Advisors sold 1,551 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $19K.
Perceptive Advisors first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 5 quarters.
Perceptive Advisors's Ariad Pharmaceuticals Inc position peaked at $2.63M in Q3 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.